{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:34:21Z","timestamp":1778016861854,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,4]],"date-time":"2009-09-04T00:00:00Z","timestamp":1252022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,9,4]],"date-time":"2009-09-04T00:00:00Z","timestamp":1252022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00535-009-0122-y","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T01:09:10Z","timestamp":1251940150000},"page":"68-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Annarosa","family":"Floreani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Porzionato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Variola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Colavito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberta","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Guido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Caro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora V.","family":"Bergasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,4]]},"reference":[{"key":"122_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd1495","volume":"3","author":"V Di Marzo","year":"2004","unstructured":"Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov. 2004;3:771\u201384.","journal-title":"Nat Rev Drug Discov"},{"key":"122_CR2","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.amjmed.2006.11.013","volume":"120","author":"SC Woods","year":"2007","unstructured":"Woods SC. The endocannabinoid system: mechanisms behind metabolic homeostasis and imbalance. Am J Med. 2007;120:S9\u201317.","journal-title":"Am J Med"},{"key":"122_CR3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","volume":"128","author":"B Julien","year":"2005","unstructured":"Julien B, Grenard P, Teixeira-Clerc F, Tran Van Nhieu J, Li L, Karsak M, et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology. 2005;128:742\u201355.","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"122_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2826.2008.01679.x","volume":"20","author":"P Caraceni","year":"2008","unstructured":"Caraceni P, Domenicali M, Bernardi M. The endocannabinoid system and liver diseases. J Neuroendocrinol. 2008;20(suppl 1):47\u201352.","journal-title":"J Neuroendocrinol"},{"key":"122_CR5","doi-asserted-by":"publisher","first-page":"G357","DOI":"10.1152\/ajpgi.00456.2007","volume":"294","author":"SD Siegmund","year":"2008","unstructured":"Siegmund SD, Shwabe RF. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2008;294:G357\u201362.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"122_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/hep.20733","volume":"42","author":"C Hezode","year":"2005","unstructured":"Hezode C, Roudot-Thoraval F, Nguyen S, Grenard P, Julien B, Zafrani ES, et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology. 2005;42:63\u201371.","journal-title":"Hepatology"},{"key":"122_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nri1602","volume":"5","author":"TW Klein","year":"2005","unstructured":"Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol. 2005;5:400\u201311.","journal-title":"Nat Rev Immunol"},{"key":"122_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0303101","volume":"74","author":"TW Klein","year":"2003","unstructured":"Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, et al. The cannabinoid system and immune modulation. J Leukoc Biol. 2003;74:486\u201396.","journal-title":"J Leukoc Biol"},{"key":"122_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(00)00184-5","volume":"108","author":"M Mechoulam","year":"2000","unstructured":"Mechoulam M, Hanus L. A historical overview of chemical research on cannabinoids. Chem Phys Lipids. 2000;108:1\u201313.","journal-title":"Chem Phys Lipids"},{"key":"122_CR10","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/cbdv.200790160","volume":"4","author":"AG Norrod","year":"2007","unstructured":"Norrod AG, Puffenbarger RA. Genetic polymorphisms of the endocannabinoid system. Chem Biodivers. 2007;4:1926\u201332.","journal-title":"Chem Biodivers"},{"key":"122_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/mcpr.1999.0249","volume":"13","author":"D Gadzicki","year":"1999","unstructured":"Gadzicki D, Muller-Vahl K, Stuhrmann M. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol Cell Probes. 1999;13:321\u20135.","journal-title":"Mol Cell Probes"},{"key":"122_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1189\/jlb.0205111","volume":"78","author":"JC Sipe","year":"2005","unstructured":"Sipe JC, Arbour N, Gerber A, Beutler E. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol. 2005;78:231\u20138.","journal-title":"J Leukoc Biol"},{"key":"122_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0009-3084(00)00195-X","volume":"108","author":"EV Berdyshev","year":"2000","unstructured":"Berdyshev EV. Cannabinoid receptors and the regulation of the immune response. Chem Phys Lipids. 2000;108:169\u201390.","journal-title":"Chem Phys Lipids"},{"key":"122_CR14","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","volume":"97","author":"GW Neef","year":"2002","unstructured":"Neef GW, O\u2019Brien CB, Reddy KR, Bergasa NV, Regev A, Molina E, et al. Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. Am J Gastroenterol. 2002;97:2117\u20139.","journal-title":"Am J Gastroenterol"},{"key":"122_CR15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/hep.21165","volume":"43","author":"A Floreani","year":"2006","unstructured":"Floreani A, Carderi I, Variola A, Rizzotto ER, Nicol J, Bergasa NV. A novel multidrug resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus. Hepatology. 2006;43:1152\u20134.","journal-title":"Hepatology"},{"key":"122_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2340\/00015555-0436","volume":"88","author":"LX Wei","year":"2008","unstructured":"Wei LX, Floreani A, Variola A, El Younis C, Bergasa NV. A study of the mu opioid receptor gene polymorphism A118G in patients with primary biliary cirrhosis with and without pruritus. Acta Derm Venerol. 2008;88:323\u20136.","journal-title":"Acta Derm Venerol"},{"key":"122_CR17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/003591576706001205","volume":"60","author":"PJ Scheuer","year":"1967","unstructured":"Scheuer PJ. Primary biliary cirrhosis. Proc Roy Soc Med. 1967;60:1257\u201360.","journal-title":"Proc Roy Soc Med"},{"key":"122_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Par\u00e9s","year":"2006","unstructured":"Par\u00e9s A, Llorenc Caballeria, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 2006;130:715\u201320.","journal-title":"Gastroenterology"},{"key":"122_CR19","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1136\/gut.2008.148791","volume":"57","author":"AA Izzo","year":"2008","unstructured":"Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008;57:1140\u201355.","journal-title":"Gut"},{"key":"122_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1478-3231.2004.0945.x","volume":"24","author":"CM Fernandez-Rodriguez","year":"2004","unstructured":"Fernandez-Rodriguez CM, Romero J, Petros TJ, Bradshaw H, Gasalla JM, Gutierrez ML, et al. Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. Liver Int. 2004;24:477\u201383.","journal-title":"Liver Int"},{"key":"122_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nm1421","volume":"12","author":"F Teixeira-Clerc","year":"2006","unstructured":"Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med. 2006;12:671\u20136.","journal-title":"Nat Med"},{"key":"122_CR22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1096\/fj.06-7451com","volume":"21","author":"S Batkai","year":"2007","unstructured":"Batkai S, Osei-Hyiaman D, Pan H, El-Assal O, Rajesh M, Mukhopadhyay P, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia\/reperfusion injury. FASEB J. 2007;21:1788\u2013800.","journal-title":"FASEB J"},{"issue":"suppl. 1","key":"122_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","volume":"56","author":"N Stella","year":"2009","unstructured":"Stella N. Endocannabinoid signalling in microglial cells. Neuropharmacology. 2009;56(suppl. 1):244\u201353.","journal-title":"Neuropharmacology"},{"key":"122_CR24","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1124\/mol.56.6.1362","volume":"56","author":"M Glass","year":"1999","unstructured":"Glass M, Northup JK. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol Pharmacol. 1999;56:1362\u20139.","journal-title":"Mol Pharmacol"},{"key":"122_CR25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, Depetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, et al. Endocannabinoid activation at hepatic CB(1) receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest. 2005;115:1298\u2013305.","journal-title":"J Clin Invest"},{"key":"122_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mam.2007.09.007","volume":"29","author":"D Alvaro","year":"2008","unstructured":"Alvaro D, Mancino MG. New insights on the molecular and cell biology of human cholangiopathies. Mol Aspects Med. 2008;29:50\u20137.","journal-title":"Mol Aspects Med"},{"key":"122_CR27","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","volume":"127","author":"KN Lazaridis","year":"2004","unstructured":"Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology. 2004;127:1565\u201377.","journal-title":"Gastroenterology"},{"key":"122_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/gut.46.1.121","volume":"46","author":"M Leuchner","year":"2000","unstructured":"Leuchner M, Dietrich CF, You T, Seidl C, Raedle J, Hermann G, et al. Characterization of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut. 2000;46:121\u20136.","journal-title":"Gut"},{"key":"122_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/sj.bjp.0707478","volume":"152","author":"Y Sun","year":"2007","unstructured":"Sun Y, Alexander SP, Garle MJ, Gibson CL, Hewitt K, Murphy SP, et al. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. Br J Pharmacol. 2007;152:734\u201343.","journal-title":"Br J Pharmacol"},{"key":"122_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/sj.bjp.0707352","volume":"151","author":"A Lenman","year":"2007","unstructured":"Lenman A, Fowler CJ. Interaction of ligands for the peroxisome proliferators-activated receptor \u03b3 with the endocannabinoid system. Br J Pharmacol. 2007;151:1343\u201351.","journal-title":"Br J Pharmacol"},{"key":"122_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1021\/mp060010s","volume":"3","author":"G Zollner","year":"2006","unstructured":"Zollner G, Marschall HU, Wagner M, Trauner M. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm. 2006;3:231\u201351.","journal-title":"Mol Pharm"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-009-0122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-009-0122-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-009-0122-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-009-0122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:43:54Z","timestamp":1684867434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-009-0122-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["122"],"URL":"https:\/\/doi.org\/10.1007\/s00535-009-0122-y","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,4]]},"assertion":[{"value":"2 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}